Skip to main content
Log in

The prevalence of Parkinson's disease in Portugal

A population approach

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Most of the epidemiological studies designed to determine the prevalence of Parkinson's disease (PD) in Portugal were hospital-based and the rates reported were around 1/1000. A sentinel network of general practitioners (GPs) has been in effect in the country since 1989, involving doctors with a relatively stable list of patients. This group of doctors notifies, every week, all the cases of certain selected diseases that may occur among the patients under their surveillance. On average, each doctor is responsible for 1500 to 1800 persons, of all ages and both sexes, whose main descriptive characteristics are known and updated every year. This led us to the idea of estimating the prevalence of Parkinson's disease in the community and to compare the estimated rates with hospital-based rates. One hundred and fifty general practitioners agreed to participate in a cross-sectional study which included a sample of 220,000 persons. The study took place between March and April 1992 and information on 291 PD patients was collected. Results show that among the study population, age-standardized rates were 1.4/1000 for males and 1.3/1000 for females. Sex-specific rates increase consistently with age in both sexes, reaching a level of 9/1000 in the oldest age group, ‘75 and more’ years. These results estimate a higher prevalence of PD than was determined previously through hospital-based studies and allowed us to determine that patients aged 65 years and more are much likely to be followed by their own GP, either because the disease its already controlled and they are specifically seeking medication or because they find it difficult to attend neurology clinics. To attain a more comprehensive care of such patients, a good collaboration should be guaranteed between the primary care level and the referral neurologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Briz T, The Portuguese Society of Neurology. Parkinsonism in Portugal: A cross-sectional study, first results. Arch Nat Inst Health 1988; 13: 51–101.

    Google Scholar 

  2. Cuesta JP. Studies on the prevalence of paralysis agitans by tracer methodology. Acta Neur Scand 1987; Suppl 112,75: 8.

    Google Scholar 

  3. Lima B. Parkinson's disease. Geriatry 1989: 32–37.

  4. Falcäo JM. Sentinel Doctors: 9 steps ahead. Health in Numbers 1990; 5 (3): 17–21.

    Google Scholar 

  5. Ashton Tate Corporation. DBASEIII Plus, Version 1.0. Arlington, MA, 1986.

  6. Dean J, Dean A, Burton A, Dicker R. Epi Info, Version 5.00, C.D.C. Atlanta, GA, 1989.

  7. Calne (Department of Neurology, University of British Columbia, Vancouver, Canada) Screening Questionnaire for Parkingson's Disease.

  8. Duarte J, et al. Screening Parkinson's disease at lower cost: A validated complementary questionnaire. Clin Neur Gen Hospital of Segovia, Segovia, Spain, 1992 (not published manuscript).

  9. Merck Sharp & Dohme, Lda. Sinemet sales in Portugal, 1991. Lisbon (Portugal), 1992.

  10. Roche Farmacêutica Clínica, Lda. Madopar sales in Portugal, 1991. Lisbon (Portugal), 1992.

  11. Dias JAA, Felgueiras MM, Sachez JP, Marau J, Falcäo JM, Pimenta ZP. Parkinson's disease in Portugal: Estimated prevalence based upon a GPs sentinel network. Port Rev Neurology 1993; 2 (1): 19–30.

    Google Scholar 

  12. Health Information Service — DGCSP. Risk of dying in Portugal. Lisbon (Portugal), 1990, No. 169.

  13. Dupont E. Epidemiology of Parkinsonism: The Parkinson's investigation. In: Symposium on Parkinsonism. Lisbon (Portugal): MercK Sharp & Dohme, 1977.

    Google Scholar 

  14. Gudmunson KRA. A clinical survey of parkinsonism in Iceland. Acta Neur Scand 1967; Suppl 33, 43: 9–61.

    Google Scholar 

  15. Martilla RJ, Rime UK. Epidemiology of Parkinson's disease in Finland. Acta Neur Scand 1976; 53: 81–102.

    Google Scholar 

  16. Mutch WJ, Dyngwall-Forduce I, et al. Parkinson's disease in a Scottish city. Br Med J 1986; 292: 534–536.

    Google Scholar 

  17. Rosati G, Gronien E, et al. The risk of Parkinson's disease in Mediterranean people. Neurology 1980; 30: 250–235.

    Google Scholar 

  18. Sutcliffe RLG, Prior R, et al. Parkinson's disease in the district of Northampton Health Authority, UK: A study of prevalence and disability. Acta Neur Scand 1985; 72: 363–379.

    Google Scholar 

  19. Cuesta JP. Parkinson's disease occurrence in Europe. Acta Neur Scand 1991; 84: 357–365.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dias, J.A., Felgueiras, M.M., Sanchez, J.P. et al. The prevalence of Parkinson's disease in Portugal. Eur J Epidemiol 10, 763–767 (1994). https://doi.org/10.1007/BF01719295

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01719295

Key words

Navigation